The visual electrophysiology market is anticipated to flourish at a steady CAGR of 7.0% between 2023 and 2033. The market is expected to hold a market share of US$ 458.9 million by 2033 while the market is likely to reach a value of US$ 234.1 million in 2023.
New technology, materials, and techniques to produce innovative practice solutions significantly contribute to global market growth. In addition to this, the ease of handling visual electrophysiology devices is surging its adoption in home and alternate care settings.
There is spreading awareness of the requirement for occasional eye examinations for early diagnosis of visual disorders. Therefore retinal electrophysiology is expected to surge the demand for visual electrophysiology.
The market size is expected to increase due to the device’s portability and frequent technological advances. The versatility of visual electrophysiology devices for use on adults, children, or animals of all sizes for clinical and research purposes propels its demand.
| Attributes | Details |
|---|---|
| Visual Electrophysiology Market CAGR (2023 to 2033) | 7.0% |
| Visual Electrophysiology Market Size (2023) | US$ 234.1 million |
| Visual Electrophysiology Market Size (2033) | US$ 458.9 million |
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
Rising technological developments and increasing investments in visual electrophysiology devices are expected to boost market growth. Furthermore, the increasing geriatric population in various parts of the world surges the demand for visual electrophysiology.
Rising expenditures in healthcare advancements and growing adoption practice for visual electrophysiology diagnosis are likely to expand the market size. Moreover, the rising prevalence of neurological and eye disorders are key factors that drive the market growth.
Influx funding for research studies, government initiatives, and awareness programs are growing awareness of the benefits of visual electrophysiology. Additionally, using an electroretinogram (ERG) to eliminate any ophthalmic diseases and establishing correct diagnoses are likely to drive the visual electrophysiology adoption trends.
High costs associated with the diagnosis and treatment procedures, along with the lack of experience in using advanced technologies, pose a threat to this market. Moreover, rigid regulations by the government for recording electrical signals in the electrophysiological test are further expected to hinder market growth.
The absence of skilled professionals and the availability of property healthcare infrastructure in developing economies might hamper the visual electrophysiology market.
Principal Consultant
Growing awareness about the adverse effects of visual and neurological disorders is likely to generate revenue opportunities for the market. Furthermore, increasing research and development (R&D) activities, and technological developments, are expected to accelerate market growth.
Modernization in healthcare devices creates significant opportunities for the market. Additionally, the increasing funding by various governments worldwide is expected to provide growth opportunities. It is important to note that authorities across the world are conducting awareness programs regarding such kinds of tests. This is expected to change the visual electrophysiology market outlook.
| Countries | Revenue Share % (2022) |
|---|---|
| The United States | 33.4% |
| Germany | 5.3% |
| Japan | 3.9% |
| North America | 36.1% |
| Europe | 25.9% |
| Countries | CAGR % (2023 to 2033) |
|---|---|
| China | 8.4% |
| India | 7.1% |
| The United Kingdom | 5.4% |
| Australia | 5.7% |
North America holds a notable share of the visual electrophysiology market with a significant revenue of 33%. During the forecast period, the market share is anticipated to expand. This is because of the increasing investments being made in research and development in the region.
There have been increasing cases of eye-related disorders in the region, which is expected to surge the market growth of visual electrophysiology further. Moreover, the ability to be used across age groups is expected to drive this market.
Europe’s visual electrophysiology market held a market share of 25.9% in 2022. Increasing cases of cancer in the region are expected to fuel the growth of the market. Moreover, the rapid advancements in technology are expected to further the rise of this market.
The government in this region is proactive when it comes to dealing with the physical well-being of the population. Therefore, awareness programs are expected to shape the visual electrophysiology market trends in the region.
Asia Pacific is a growing visual electrophysiology market. Improvement of healthcare facilities and economic conditions are likely to surge the market growth.
Japan is also likely to hold a significant market share, owing to the presence of a technologically developed structure. The growing awareness about the importance of eye health is anticipated to bolster the visual electrophysiology market share, in this region. In Asia Pacific as well, increasing investments are being made in research and development, which is expected to drive the market.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
| Category | By Test Type |
|---|---|
| Leading Segment | Electroretinogram (ERG) |
| Market Share% (2022) | 38.80% |
| Category | By Modality |
|---|---|
| Leading Segment | Fixed |
| Market Share% (2022) | 65.90% |
Based on test type, the electroretinogram segment leads the market as it held a market share of 38.80% in 2022. On the other side, the modality category is led by the fixed type segment due to the high consumption. The segment held a market share of 65.90% in 2022.
The ability to locate problems at the early stage and to eliminate specific conditions are increasing the popularity of visual electrophysiology. The startups are offering training to cover recent information on new technology, materials, and techniques for innovative practice solutions. Moreover, certain start-up companies are using traditional methods combined with substantial research and development (R&D) activities. For example,
How is the Competitive Landscape in the Visual Electrophysiology Market?
The extensive range of applications including diagnosis, elimination of specific conditions, locating problems at some level of the visual system, etc. is driving key players to improve devices for visual electrophysiology. This is done through research and development (R&D) activities, for clinical and research purposes.
Recent Developments
Key Region:
The market in China is expected to record a CAGR of 8.4% through 2033.
Abbott, Biosense Webster Inc., Biotronik are the prominent market players.
The industry is forecast to record a CAGR of 7.0% through 2033.
The industry is expected to reach US$ 458.9 million by 2033.
Europe’s visual electrophysiology market held a market share of 25.9% in 2022.
1. Executive Summary 1.1. Global Market Outlook 1.2. Demand-side Trends 1.3. Supply-side Trends 1.4. Technology Roadmap Analysis 1.5. Analysis and Recommendations 2. Market Overview 2.1. Market Coverage / Taxonomy 2.2. Market Definition / Scope / Limitations 3. Market Background 3.1. Market Dynamics 3.1.1. Drivers 3.1.2. Restraints 3.1.3. Opportunity 3.1.4. Trends 3.2. Scenario Forecast 3.2.1. Demand in Optimistic Scenario 3.2.2. Demand in Likely Scenario 3.2.3. Demand in Conservative Scenario 3.3. Opportunity Map Analysis 3.4. Investment Feasibility Matrix 3.5. PESTLE and Porter’s Analysis 3.6. Regulatory Landscape 3.6.1. By Key Regions 3.6.2. By Key Countries 3.7. Regional Parent Market Outlook 4. Global Market Analysis 2018 to 2022 and Forecast, 2023 to 2033 4.1. Historical Market Size Value (US$ Million) Analysis, 2018 to 2022 4.2. Current and Future Market Size Value (US$ Million) Projections, 2023 to 2033 4.2.1. Y-o-Y Growth Trend Analysis 4.2.2. Absolute $ Opportunity Analysis 5. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Test Type 5.1. Introduction / Key Findings 5.2. Historical Market Size Value (US$ Million) Analysis By Test Type, 2018 to 2022 5.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Test Type, 2023 to 2033 5.3.1. Electroretinogram (ERG) 5.3.2. Multifocal Electroretinogram (mfERG) 5.3.3. Electro-Oculogram (EOG) 5.3.4. Visual-Evoked Responses (VER) 5.4. Y-o-Y Growth Trend Analysis By Test Type, 2018 to 2022 5.5. Absolute $ Opportunity Analysis By Test Type, 2023 to 2033 6. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Modality 6.1. Introduction / Key Findings 6.2. Historical Market Size Value (US$ Million) Analysis By Modality, 2018 to 2022 6.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Modality, 2023 to 2033 6.3.1. Fixed 6.3.2. Portable 6.4. Y-o-Y Growth Trend Analysis By Modality, 2018 to 2022 6.5. Absolute $ Opportunity Analysis By Modality, 2023 to 2033 7. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By End User 7.1. Introduction / Key Findings 7.2. Historical Market Size Value (US$ Million) Analysis by End User, 2018 to 2022 7.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast by End User, 2023 to 2033 7.3.1. Hospitals 7.3.2. Clinics 7.3.3. Ambulatory Surgical Centers 7.3.4. Diagnostic Imaging Centers 7.4. Y-o-Y Growth Trend Analysis by End User, 2018 to 2022 7.5. Absolute $ Opportunity Analysis by End User, 2023 to 2033 8. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Region 8.1. Introduction 8.2. Historical Market Size Value (US$ Million) Analysis By Region, 2018 to 2022 8.3. Current Market Size Value (US$ Million) Analysis and Forecast By Region, 2023 to 2033 8.3.1. North America 8.3.2. Latin America 8.3.3. Western Europe 8.3.4. Eastern Europe 8.3.5. South Asia and Pacific 8.3.6. East Asia 8.3.7. Middle East and Africa 8.4. Market Attractiveness Analysis By Region 9. North America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 9.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022 9.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 9.2.1. By Country 9.2.1.1. The USA 9.2.1.2. Canada 9.2.2. By Test Type 9.2.3. By Modality 9.2.4. By End User 9.3. Market Attractiveness Analysis 9.3.1. By Country 9.3.2. By Test Type 9.3.3. By Modality 9.3.4. By End User 9.4. Key Takeaways 10. Latin America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 10.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022 10.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 10.2.1. By Country 10.2.1.1. Brazil 10.2.1.2. Mexico 10.2.1.3. Rest of Latin America 10.2.2. By Test Type 10.2.3. By Modality 10.2.4. By End User 10.3. Market Attractiveness Analysis 10.3.1. By Country 10.3.2. By Test Type 10.3.3. By Modality 10.3.4. By End User 10.4. Key Takeaways 11. Western Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 11.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022 11.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 11.2.1. By Country 11.2.1.1. Germany 11.2.1.2. United Kingdom 11.2.1.3. France 11.2.1.4. Spain 11.2.1.5. Italy 11.2.1.6. Rest of Western Europe 11.2.2. By Test Type 11.2.3. By Modality 11.2.4. By End User 11.3. Market Attractiveness Analysis 11.3.1. By Country 11.3.2. By Test Type 11.3.3. By Modality 11.3.4. By End User 11.4. Key Takeaways 12. Eastern Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 12.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022 12.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 12.2.1. By Country 12.2.1.1. Poland 12.2.1.2. Russia 12.2.1.3. Czech Republic 12.2.1.4. Romania 12.2.1.5. Rest of Eastern Europe 12.2.2. By Test Type 12.2.3. By Modality 12.2.4. By End User 12.3. Market Attractiveness Analysis 12.3.1. By Country 12.3.2. By Test Type 12.3.3. By Modality 12.3.4. By End User 12.4. Key Takeaways 13. South Asia and Pacific Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 13.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022 13.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 13.2.1. By Country 13.2.1.1. India 13.2.1.2. Bangladesh 13.2.1.3. Australia 13.2.1.4. New Zealand 13.2.1.5. Rest of South Asia and Pacific 13.2.2. By Test Type 13.2.3. By Modality 13.2.4. By End User 13.3. Market Attractiveness Analysis 13.3.1. By Country 13.3.2. By Test Type 13.3.3. By Modality 13.3.4. By End User 13.4. Key Takeaways 14. East Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 14.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022 14.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 14.2.1. By Country 14.2.1.1. China 14.2.1.2. Japan 14.2.1.3. South Korea 14.2.2. By Test Type 14.2.3. By Modality 14.2.4. By End User 14.3. Market Attractiveness Analysis 14.3.1. By Country 14.3.2. By Test Type 14.3.3. By Modality 14.3.4. By End User 14.4. Key Takeaways 15. Middle East and Africa Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 15.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022 15.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 15.2.1. By Country 15.2.1.1. GCC Countries 15.2.1.2. South Africa 15.2.1.3. Israel 15.2.1.4. Rest of MEA 15.2.2. By Test Type 15.2.3. By Modality 15.2.4. By End User 15.3. Market Attractiveness Analysis 15.3.1. By Country 15.3.2. By Test Type 15.3.3. By Modality 15.3.4. By End User 15.4. Key Takeaways 16. Key Countries Market Analysis 16.1. USA 16.1.1. Pricing Analysis 16.1.2. Market Share Analysis, 2022 16.1.2.1. By Test Type 16.1.2.2. By Modality 16.1.2.3. By End User 16.2. Canada 16.2.1. Pricing Analysis 16.2.2. Market Share Analysis, 2022 16.2.2.1. By Test Type 16.2.2.2. By Modality 16.2.2.3. By End User 16.3. Brazil 16.3.1. Pricing Analysis 16.3.2. Market Share Analysis, 2022 16.3.2.1. By Test Type 16.3.2.2. By Modality 16.3.2.3. By End User 16.4. Mexico 16.4.1. Pricing Analysis 16.4.2. Market Share Analysis, 2022 16.4.2.1. By Test Type 16.4.2.2. By Modality 16.4.2.3. By End User 16.5. Germany 16.5.1. Pricing Analysis 16.5.2. Market Share Analysis, 2022 16.5.2.1. By Test Type 16.5.2.2. By Modality 16.5.2.3. By End User 16.6. United Kingdom 16.6.1. Pricing Analysis 16.6.2. Market Share Analysis, 2022 16.6.2.1. By Test Type 16.6.2.2. By Modality 16.6.2.3. By End User 16.7. France 16.7.1. Pricing Analysis 16.7.2. Market Share Analysis, 2022 16.7.2.1. By Test Type 16.7.2.2. By Modality 16.7.2.3. By End User 16.8. Spain 16.8.1. Pricing Analysis 16.8.2. Market Share Analysis, 2022 16.8.2.1. By Test Type 16.8.2.2. By Modality 16.8.2.3. By End User 16.9. Italy 16.9.1. Pricing Analysis 16.9.2. Market Share Analysis, 2022 16.9.2.1. By Test Type 16.9.2.2. By Modality 16.9.2.3. By End User 16.10. Poland 16.10.1. Pricing Analysis 16.10.2. Market Share Analysis, 2022 16.10.2.1. By Test Type 16.10.2.2. By Modality 16.10.2.3. By End User 16.11. Russia 16.11.1. Pricing Analysis 16.11.2. Market Share Analysis, 2022 16.11.2.1. By Test Type 16.11.2.2. By Modality 16.11.2.3. By End User 16.12. Czech Republic 16.12.1. Pricing Analysis 16.12.2. Market Share Analysis, 2022 16.12.2.1. By Test Type 16.12.2.2. By Modality 16.12.2.3. By End User 16.13. Romania 16.13.1. Pricing Analysis 16.13.2. Market Share Analysis, 2022 16.13.2.1. By Test Type 16.13.2.2. By Modality 16.13.2.3. By End User 16.14. India 16.14.1. Pricing Analysis 16.14.2. Market Share Analysis, 2022 16.14.2.1. By Test Type 16.14.2.2. By Modality 16.14.2.3. By End User 16.15. Bangladesh 16.15.1. Pricing Analysis 16.15.2. Market Share Analysis, 2022 16.15.2.1. By Test Type 16.15.2.2. By Modality 16.15.2.3. By End User 16.16. Australia 16.16.1. Pricing Analysis 16.16.2. Market Share Analysis, 2022 16.16.2.1. By Test Type 16.16.2.2. By Modality 16.16.2.3. By End User 16.17. New Zealand 16.17.1. Pricing Analysis 16.17.2. Market Share Analysis, 2022 16.17.2.1. By Test Type 16.17.2.2. By Modality 16.17.2.3. By End User 16.18. China 16.18.1. Pricing Analysis 16.18.2. Market Share Analysis, 2022 16.18.2.1. By Test Type 16.18.2.2. By Modality 16.18.2.3. By End User 16.19. Japan 16.19.1. Pricing Analysis 16.19.2. Market Share Analysis, 2022 16.19.2.1. By Test Type 16.19.2.2. By Modality 16.19.2.3. By End User 16.20. South Korea 16.20.1. Pricing Analysis 16.20.2. Market Share Analysis, 2022 16.20.2.1. By Test Type 16.20.2.2. By Modality 16.20.2.3. By End User 16.21. GCC Countries 16.21.1. Pricing Analysis 16.21.2. Market Share Analysis, 2022 16.21.2.1. By Test Type 16.21.2.2. By Modality 16.21.2.3. By End User 16.22. South Africa 16.22.1. Pricing Analysis 16.22.2. Market Share Analysis, 2022 16.22.2.1. By Test Type 16.22.2.2. By Modality 16.22.2.3. By End User 16.23. Israel 16.23.1. Pricing Analysis 16.23.2. Market Share Analysis, 2022 16.23.2.1. By Test Type 16.23.2.2. By Modality 16.23.2.3. By End User 17. Market Structure Analysis 17.1. Competition Dashboard 17.2. Competition Benchmarking 17.3. Market Share Analysis of Top Players 17.3.1. By Regional 17.3.2. By Test Type 17.3.3. By Modality 17.3.4. By End User 18. Competition Analysis 18.1. Competition Deep Dive 18.1.1. Metrovision 18.1.1.1. Overview 18.1.1.2. Product Portfolio 18.1.1.3. Profitability by Market Segments 18.1.1.4. Sales Footprint 18.1.1.5. Strategy Overview 18.1.1.5.1. Marketing Strategy 18.1.2. Konan Medical USA 18.1.2.1. Overview 18.1.2.2. Product Portfolio 18.1.2.3. Profitability by Market Segments 18.1.2.4. Sales Footprint 18.1.2.5. Strategy Overview 18.1.2.5.1. Marketing Strategy 18.1.3. Diopsys Inc 18.1.3.1. Overview 18.1.3.2. Product Portfolio 18.1.3.3. Profitability by Market Segments 18.1.3.4. Sales Footprint 18.1.3.5. Strategy Overview 18.1.3.5.1. Marketing Strategy 18.1.4. Nationwide Children’s Hospital 18.1.4.1. Overview 18.1.4.2. Product Portfolio 18.1.4.3. Profitability by Market Segments 18.1.4.4. Sales Footprint 18.1.4.5. Strategy Overview 18.1.4.5.1. Marketing Strategy 18.1.5. The Royal College of Ophthalmologists 18.1.5.1. Overview 18.1.5.2. Product Portfolio 18.1.5.3. Profitability by Market Segments 18.1.5.4. Sales Footprint 18.1.5.5. Strategy Overview 18.1.5.5.1. Marketing Strategy 18.1.6. LKC Technologies Inc. 18.1.6.1. Overview 18.1.6.2. Product Portfolio 18.1.6.3. Profitability by Market Segments 18.1.6.4. Sales Footprint 18.1.6.5. Strategy Overview 18.1.6.5.1. Marketing Strategy 18.1.7. Boston Scientific Corporation 18.1.7.1. Overview 18.1.7.2. Product Portfolio 18.1.7.3. Profitability by Market Segments 18.1.7.4. Sales Footprint 18.1.7.5. Strategy Overview 18.1.7.5.1. Marketing Strategy 18.1.8. Abbott 18.1.8.1. Overview 18.1.8.2. Product Portfolio 18.1.8.3. Profitability by Market Segments 18.1.8.4. Sales Footprint 18.1.8.5. Strategy Overview 18.1.8.5.1. Marketing Strategy 18.1.9. Biosense Webster Inc. 18.1.9.1. Overview 18.1.9.2. Product Portfolio 18.1.9.3. Profitability by Market Segments 18.1.9.4. Sales Footprint 18.1.9.5. Strategy Overview 18.1.9.5.1. Marketing Strategy 18.1.10. Biotronik 18.1.10.1. Overview 18.1.10.2. Product Portfolio 18.1.10.3. Profitability by Market Segments 18.1.10.4. Sales Footprint 18.1.10.5. Strategy Overview 18.1.10.5.1. Marketing Strategy 18.1.11. General Electric Company 18.1.11.1. Overview 18.1.11.2. Product Portfolio 18.1.11.3. Profitability by Market Segments 18.1.11.4. Sales Footprint 18.1.11.5. Strategy Overview 18.1.11.5.1. Marketing Strategy 18.1.12. Siemens Healthcare GmbH 18.1.12.1. Overview 18.1.12.2. Product Portfolio 18.1.12.3. Profitability by Market Segments 18.1.12.4. Sales Footprint 18.1.12.5. Strategy Overview 18.1.12.5.1. Marketing Strategy 18.1.13. MicroPort Scientific Corporation 18.1.13.1. Overview 18.1.13.2. Product Portfolio 18.1.13.3. Profitability by Market Segments 18.1.13.4. Sales Footprint 18.1.13.5. Strategy Overview 18.1.13.5.1. Marketing Strategy 18.1.14. Koninklijke Philips N.V. 18.1.14.1. Overview 18.1.14.2. Product Portfolio 18.1.14.3. Profitability by Market Segments 18.1.14.4. Sales Footprint 18.1.14.5. Strategy Overview 18.1.14.5.1. Marketing Strategy 18.1.15. NIHON KOHDEN CORPORATION 18.1.15.1. Overview 18.1.15.2. Product Portfolio 18.1.15.3. Profitability by Market Segments 18.1.15.4. Sales Footprint 18.1.15.5. Strategy Overview 18.1.15.5.1. Marketing Strategy 18.1.16. CardioFocus 18.1.16.1. Overview 18.1.16.2. Product Portfolio 18.1.16.3. Profitability by Market Segments 18.1.16.4. Sales Footprint 18.1.16.5. Strategy Overview 18.1.16.5.1. Marketing Strategy 18.1.17. Stereotaxis Inc. 18.1.17.1. Overview 18.1.17.2. Product Portfolio 18.1.17.3. Profitability by Market Segments 18.1.17.4. Sales Footprint 18.1.17.5. Strategy Overview 18.1.17.5.1. Marketing Strategy 18.1.18. Molecular Devices LLC 18.1.18.1. Overview 18.1.18.2. Product Portfolio 18.1.18.3. Profitability by Market Segments 18.1.18.4. Sales Footprint 18.1.18.5. Strategy Overview 18.1.18.5.1. Marketing Strategy 19. Assumptions & Acronyms Used 20. Research Methodology
Explore Healthcare Insights
View Reports
Visual Electrophysiology Market
